Brughera Marco Maria
SEC Form 4 insider trading activity
Brughera Marco Maria has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.
On the most recent filing, Brughera Marco Maria is listed as Director at FENNEC PHARMACEUTICALS INC. Inside the rolling window, Brughera Marco Maria reported no open-market purchases and 1 open-market sale totaling $160K in FENC.
Companies traded
Other insiders at FENC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$160K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brughera Marco Maria made?
Brughera Marco Maria has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Brughera Marco Maria trade?
Brughera Marco Maria has filed SEC Form 4 disclosures for 1 company, including FENC.
When was Brughera Marco Maria's most recent SEC Form 4 filing?
Brughera Marco Maria's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.
What is Brughera Marco Maria's total buy and sell value in the current window?
Inside the rolling retention window, Brughera Marco Maria bought $0 and sold $160K based on SEC Form 4 filings.
What was Brughera Marco Maria's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,545 FENC shares on 2026-09-15, worth $160K, per SEC Form 4 filings.